•  : 
  •  : 


Brand Name:- Libtayo

Generic Name:- Cemiplimab-rwlc

Manufacturer:- Sanofi

Dosage:- Injection

Strength:- 350mg/7ml (50mg/ml)

Composition:- Cemiplimab-rwlc

Packaging:- 1vial

Indication:- Skin Cancer

Storage:- Store at room temperature


Libtayo (Cemiplimab-rwlc) is used to treat a type of skin cancer that has spread to other areas of the body that cannot be treated with radiation or surgery. It is given as an infusion into the vein. Do not self-administer this medicine. Take this medicine as prescribed by your medical advisor. Your doctor will decide the exact dosage. Do not take this medicine in the wrong way as it may lead to some severe side effects. It is advisable not to change or stop the dose without taking suggestions from your doctor. If you experience any symptoms while receiving this medicine, inform your doctor immediately.

Pharmacodynamics Of Libtayo

Cemiplimab inhibits tumor growth by an immune-mediated mechanism, specifically by the inhibition of the programmed death receptor 1 (PD-1) treating cutaneous squamous cell carcinoma. 350mg IV over 30 minutes every 3 weeks until disease progression.

Side Effects Of Libtayo Injection

This medicine may cause some serious and unwanted side effects. It requires immediate medical attention otherwise it can also lead to higher risk. Discuss the risks and benefits of this medication with a medical advisor before starting the treatment.

Common Side Effects

  • Diarrhea
  • Fever
  • Cough
  • Itching
  • Abdominal pain
  • Dizziness
  • Sore throat
  • Headache
  • Nausea
  • Vomiting
  • Skin rash
  • Blurred vision
  • Difficulty in urination
  • Pale skin
  • Anxiety
  • Fainting
  • Muscle pain
  • Constipation
  • Bleeding
  • Irregular heartbeat
  • Allergic reaction
  • Chest pain
  • Seizures
  • Pounding in the ears
  • Facial swelling
  • Back or neck pain
  • Anemia
  • Change in eyesight
  • Swollen glands
  • Swelling in your ankles
  • Tingling of arms and legs
  • Skin blistering

Note- Immediately contact your doctor if side effects occur.

Take this injection as prescribed by your doctor. Do not self-administer. The injection is given as an infusion into your vein by a doctor or nurse.

Missed Dose

It is advisable not to miss a dose. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately.


In case of an overdose, the doctor will provide emergency medical treatment.

Usage Of Libtayo

This medicine is used to treat a certain type of cancer (cutaneous squamous cell carcinoma) CSCC. This medication works by changing the action of the immune system and directing it to kill or stop the growth of cancer cells. Take this medicine according to your dosing schedule. This medicine must be given slowly, it takes at least 30 minutes to complete one infusion. A medical advisor decides the dose of medicine according to your response to the treatment and your previous medical condition. Cemiplimab is given once every 3 weeks. This medicine is not recommended for breastfeeding. Protect this medicine from heat and light. Do not shake or freeze the medicine.

Before starting treatment with Libtayo, please inform your doctor about your previous medical history. If you experience any symptoms while receiving this medication, do not ignore those symptoms because it may lead to higher risk.


Use effective methods of contraception to prevent pregnancy while taking this medicine.

Children and adolescents

This medicine is not advisable for use in children and adolescents.

Warnings For Female


Libtayo shouldn’t be used by pregnant women. Cemiplimab-rwlc may cause harm to the baby. It is recommended that this medicine should be avoided during pregnancy.


This medicine is not recommended for breastfeeding unless it is necessary. Please consult your medical advisor before starting treatment with this medication.

General Warning And Precautions

  • Do not receive any vaccine during your treatment with this medicine.
  • This medicine may cause immune-related problems.
  • A regular blood test is required to check the side effects.
  • Do not breastfeed while taking cemiplimab.
  • Avoid contact with people who have infections.
  • Libtayo can immune-mediated thyroid disorders.


  • Not safe for pregnant women.
  • Do not drive or operate heavy machinery.
  • Do not self-administer this medicine.
  • Do not breastfeed while receiving this medication.


  •  : 
  •  :